{"id":25805,"date":"2025-08-25T07:00:49","date_gmt":"2025-08-25T06:00:49","guid":{"rendered":"https:\/\/www.cryoport.com\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/"},"modified":"2026-02-13T10:04:43","modified_gmt":"2026-02-13T15:04:43","slug":"prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea","status":"publish","type":"post","link":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/","title":{"rendered":"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l’EMEA"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Pour les d\u00e9veloppeurs de th\u00e9rapies innovantes qui se d\u00e9veloppent en Europe, l’approbation r\u00e9glementaire n’est qu’un d\u00e9but. M\u00eame apr\u00e8s avoir obtenu l’autorisation de l’Agence europ\u00e9enne des m\u00e9dicaments (EMA), les entreprises se retrouvent souvent embourb\u00e9es dans un patchwork de r\u00e8gles nationales, d’obstacles \u00e0 la fixation des prix, voire de retards d’acc\u00e8s. Lors de sa r\u00e9cente participation au podcast Beyond Biotech de Labiotech, Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial de Cryoport Systems pour la r\u00e9gion EMEA, a lev\u00e9 le voile sur ce qu’il faut vraiment faire pour apporter des th\u00e9rapies avanc\u00e9es aux patients de la r\u00e9gion. <\/p>\n","protected":false},"author":38,"featured_media":19812,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-with-related.php","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[635],"tags":[679,704,601,654],"class_list":["post-25805","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gestion-de-la-chaine-du-froid","tag-atmps","tag-fragmentation","tag-gestion-de-la-chaine-dapprovisionnement-mondiale","tag-leurope"],"acf":[],"yoast_head":"\nProchaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l'EMEA - Cryoport Systems<\/title>\n<meta name=\"description\" content=\"Pour les d\u00e9veloppeurs de th\u00e9rapies innovantes qui se d\u00e9veloppent en Europe, l'approbation r\u00e9glementaire n'est qu'un d\u00e9but. M\u00eame apr\u00e8s avoir obtenu l'autorisation de l'Agence europ\u00e9enne des m\u00e9dicaments (EMA), les entreprises se retrouvent souvent embourb\u00e9es dans un patchwork de r\u00e8gles nationales, d'obstacles tarifaires et m\u00eame de retards d'acc\u00e8s. Lors de sa r\u00e9cente participation au podcast Beyond Biotech de Labiotech, Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial de Cryoport Systems pour l'EMEA, a lev\u00e9 le voile sur ce qu'il faut vraiment faire pour apporter des th\u00e9rapies avanc\u00e9es aux patients de la r\u00e9gion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l'EMEA - Cryoport Systems\" \/>\n<meta property=\"og:description\" content=\"Pour les d\u00e9veloppeurs de th\u00e9rapies innovantes qui se d\u00e9veloppent en Europe, l'approbation r\u00e9glementaire n'est qu'un d\u00e9but. M\u00eame apr\u00e8s avoir obtenu l'autorisation de l'Agence europ\u00e9enne des m\u00e9dicaments (EMA), les entreprises se retrouvent souvent embourb\u00e9es dans un patchwork de r\u00e8gles nationales, d'obstacles tarifaires et m\u00eame de retards d'acc\u00e8s. Lors de sa r\u00e9cente participation au podcast Beyond Biotech de Labiotech, Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial de Cryoport Systems pour l'EMEA, a lev\u00e9 le voile sur ce qu'il faut vraiment faire pour apporter des th\u00e9rapies avanc\u00e9es aux patients de la r\u00e9gion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/\" \/>\n<meta property=\"og:site_name\" content=\"Cryoport Systems\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T06:00:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-13T15:04:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/08\/Whats-Next-for-ATMP-regulation-Blog.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"smendez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cryoport\" \/>\n<meta name=\"twitter:site\" content=\"@cryoport\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"smendez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/\"},\"author\":{\"name\":\"smendez\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\"},\"headline\":\"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l’EMEA\",\"datePublished\":\"2025-08-25T06:00:49+00:00\",\"dateModified\":\"2026-02-13T15:04:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/\"},\"wordCount\":13,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Whats-Next-for-ATMP-regulation-Blog.png\",\"keywords\":[\"ATMPs\",\"Fragmentation\",\"Gestion de la cha\u00eene d'approvisionnement mondiale\",\"L'Europe\"],\"articleSection\":[\"Gestion de la cha\u00eene du froid\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/\",\"name\":\"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l'EMEA - Cryoport Systems\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Whats-Next-for-ATMP-regulation-Blog.png\",\"datePublished\":\"2025-08-25T06:00:49+00:00\",\"dateModified\":\"2026-02-13T15:04:43+00:00\",\"description\":\"Pour les d\u00e9veloppeurs de th\u00e9rapies innovantes qui se d\u00e9veloppent en Europe, l'approbation r\u00e9glementaire n'est qu'un d\u00e9but. M\u00eame apr\u00e8s avoir obtenu l'autorisation de l'Agence europ\u00e9enne des m\u00e9dicaments (EMA), les entreprises se retrouvent souvent embourb\u00e9es dans un patchwork de r\u00e8gles nationales, d'obstacles tarifaires et m\u00eame de retards d'acc\u00e8s. Lors de sa r\u00e9cente participation au podcast Beyond Biotech de Labiotech, Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial de Cryoport Systems pour l'EMEA, a lev\u00e9 le voile sur ce qu'il faut vraiment faire pour apporter des th\u00e9rapies avanc\u00e9es aux patients de la r\u00e9gion.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Whats-Next-for-ATMP-regulation-Blog.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Whats-Next-for-ATMP-regulation-Blog.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l’EMEA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"name\":\"Cryoport Systems\",\"description\":\"Enabling the Future of Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\",\"name\":\"Cryoport Systems\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"width\":1200,\"height\":1200,\"caption\":\"Cryoport Systems\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/cryoport\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/856887\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/CryoportVideo\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\",\"name\":\"smendez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"caption\":\"smendez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l'EMEA - Cryoport Systems","description":"Pour les d\u00e9veloppeurs de th\u00e9rapies innovantes qui se d\u00e9veloppent en Europe, l'approbation r\u00e9glementaire n'est qu'un d\u00e9but. M\u00eame apr\u00e8s avoir obtenu l'autorisation de l'Agence europ\u00e9enne des m\u00e9dicaments (EMA), les entreprises se retrouvent souvent embourb\u00e9es dans un patchwork de r\u00e8gles nationales, d'obstacles tarifaires et m\u00eame de retards d'acc\u00e8s. Lors de sa r\u00e9cente participation au podcast Beyond Biotech de Labiotech, Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial de Cryoport Systems pour l'EMEA, a lev\u00e9 le voile sur ce qu'il faut vraiment faire pour apporter des th\u00e9rapies avanc\u00e9es aux patients de la r\u00e9gion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/","og_locale":"fr_FR","og_type":"article","og_title":"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l'EMEA - Cryoport Systems","og_description":"Pour les d\u00e9veloppeurs de th\u00e9rapies innovantes qui se d\u00e9veloppent en Europe, l'approbation r\u00e9glementaire n'est qu'un d\u00e9but. M\u00eame apr\u00e8s avoir obtenu l'autorisation de l'Agence europ\u00e9enne des m\u00e9dicaments (EMA), les entreprises se retrouvent souvent embourb\u00e9es dans un patchwork de r\u00e8gles nationales, d'obstacles tarifaires et m\u00eame de retards d'acc\u00e8s. Lors de sa r\u00e9cente participation au podcast Beyond Biotech de Labiotech, Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial de Cryoport Systems pour l'EMEA, a lev\u00e9 le voile sur ce qu'il faut vraiment faire pour apporter des th\u00e9rapies avanc\u00e9es aux patients de la r\u00e9gion.","og_url":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/","og_site_name":"Cryoport Systems","article_published_time":"2025-08-25T06:00:49+00:00","article_modified_time":"2026-02-13T15:04:43+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/08\/Whats-Next-for-ATMP-regulation-Blog.png","type":"image\/png"}],"author":"smendez","twitter_card":"summary_large_image","twitter_creator":"@cryoport","twitter_site":"@cryoport","twitter_misc":{"\u00c9crit par":"smendez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/#article","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/"},"author":{"name":"smendez","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86"},"headline":"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l’EMEA","datePublished":"2025-08-25T06:00:49+00:00","dateModified":"2026-02-13T15:04:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/"},"wordCount":13,"publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/08\/Whats-Next-for-ATMP-regulation-Blog.png","keywords":["ATMPs","Fragmentation","Gestion de la cha\u00eene d'approvisionnement mondiale","L'Europe"],"articleSection":["Gestion de la cha\u00eene du froid"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/","url":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/","name":"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l'EMEA - Cryoport Systems","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/#primaryimage"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/08\/Whats-Next-for-ATMP-regulation-Blog.png","datePublished":"2025-08-25T06:00:49+00:00","dateModified":"2026-02-13T15:04:43+00:00","description":"Pour les d\u00e9veloppeurs de th\u00e9rapies innovantes qui se d\u00e9veloppent en Europe, l'approbation r\u00e9glementaire n'est qu'un d\u00e9but. M\u00eame apr\u00e8s avoir obtenu l'autorisation de l'Agence europ\u00e9enne des m\u00e9dicaments (EMA), les entreprises se retrouvent souvent embourb\u00e9es dans un patchwork de r\u00e8gles nationales, d'obstacles tarifaires et m\u00eame de retards d'acc\u00e8s. Lors de sa r\u00e9cente participation au podcast Beyond Biotech de Labiotech, Alison Pritchard, vice-pr\u00e9sidente du d\u00e9veloppement commercial de Cryoport Systems pour l'EMEA, a lev\u00e9 le voile sur ce qu'il faut vraiment faire pour apporter des th\u00e9rapies avanc\u00e9es aux patients de la r\u00e9gion.","breadcrumb":{"@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/#primaryimage","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/08\/Whats-Next-for-ATMP-regulation-Blog.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/08\/Whats-Next-for-ATMP-regulation-Blog.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.cryoport.com\/fr\/prochaines-etapes-de-la-reglementation-des-medicaments-antiparasitaires-dans-lemea\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cryoport.com\/fr\/homepage\/"},{"@type":"ListItem","position":2,"name":"Prochaines \u00e9tapes de la r\u00e9glementation des m\u00e9dicaments antiparasitaires dans l’EMEA"}]},{"@type":"WebSite","@id":"https:\/\/www.cryoport.com\/fr\/#website","url":"https:\/\/www.cryoport.com\/fr\/","name":"Cryoport Systems","description":"Enabling the Future of Medicine","publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cryoport.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cryoport.com\/fr\/#organization","name":"Cryoport Systems","url":"https:\/\/www.cryoport.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","width":1200,"height":1200,"caption":"Cryoport Systems"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/cryoport","https:\/\/www.linkedin.com\/company\/856887","https:\/\/www.youtube.com\/user\/CryoportVideo"]},{"@type":"Person","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86","name":"smendez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","caption":"smendez"}}]}},"_links":{"self":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/25805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/comments?post=25805"}],"version-history":[{"count":1,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/25805\/revisions"}],"predecessor-version":[{"id":26371,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/25805\/revisions\/26371"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media\/19812"}],"wp:attachment":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media?parent=25805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/categories?post=25805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/tags?post=25805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}